OptiBiotix Health PLC (LON:OPTI) has signed an exclusive agreement with DKSH International to distribute its SlimBiome weight management ingredient in Italy and Spain.
In order to maintain its market exclusivity, the multi-billion-dollar Swiss firm will have to meet certain sales targets, which Opti believes will maximise the financial return for both parties.
It should also provide some surety of income over the next three years, the AIM-quoted company added.
WATCH: Extension to supply agreement 'reflects growing confidence' in OptiBiotix's LPLDL strain
“We are delighted that DKSH will be bringing their marketing and sales expertise to promote the sale of SlimBiome,” said sales and marketing director Christina Wood.
“DKSH is a highly successful global corporation with a strong positioning in both consumer goods, including foods and beverages, as well as healthcare and technology; key areas for our weight management products.”
SlimBiome is an appetite-suppressing ingredient which can be added to things such as snack bars, shakes and even coffee.
Research has shown that it can reduce hunger and cravings for sweet, fatty and savoury foods, helping people to lose as much as 3lbs a week.
Wood added: “We hope combining these attributes with DKSH's sales, marketing and distribution expertise will generate substantial revenues in the months and years ahead.”